Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 438
Filtrar
Más filtros

Medicinas Complementárias
Tipo del documento
Intervalo de año de publicación
1.
Adv Exp Med Biol ; 1384: 351-372, 2022.
Artículo en Inglés | MEDLINE | ID: mdl-36217095

RESUMEN

Hypoglossal nerve stimulation (HNS) has been shown to be a safe alternative in the treatment of moderate-to-severe obstructive sleep apnea (OSA). A recent meta-analysis of 12 studies by Costantino et al. indicated the surgical success rates at 55-75%, a reduction of the apnea hypopnea index (AHI) of 18 events/h, and a reduction of the Epworth Sleepiness Scale (ESS) of 2.9-5.3. After animal studies in the 1970s, the first trial on humans to decrease upper airway resistance by transcutaneous electrical stimulation of the genioglossus was reported in 1989. A separate stimulation of protruding and retracting muscles was realized in 1995 by fine-wire electrodes that were placed into the tongue transoral. Over the next years, several companies developed implantable devices for hypoglossal stimulation in OSA. Initially, devices were developed that used unilateral stimulation of the hypoglossal nerve. In 2014, a device for unilateral respiratory frequency-controlled hypoglossal stimulation finally received FDA approval after a successful phase III trial. In recent years, a device for bilateral breath rate-independent stimulation of the hypoglossal nerve has been added to these approaches as a new development. Accordingly, hypoglossal nerve stimulation, on the one hand, is now an established tool for patients with OSA when standard treatments are not satisfactory. Beyond that, hypoglossal stimulation is undergoing a continuous and impressive development like hardly any other field of surgical therapy for OSA.


Asunto(s)
Terapia por Estimulación Eléctrica , Apnea Obstructiva del Sueño , Resistencia de las Vías Respiratorias , Animales , Ensayos Clínicos Fase III como Asunto , Humanos , Nervio Hipogloso/fisiología , Apnea Obstructiva del Sueño/terapia , Lengua , Resultado del Tratamiento
2.
Toxicol Appl Pharmacol ; 450: 116154, 2022 09 01.
Artículo en Inglés | MEDLINE | ID: mdl-35798068

RESUMEN

Workers involved in oil exploration and production in the upstream petroleum industry are exposed to crude oil vapor (COV). COV levels in the proximity of workers during production tank gauging and opening of thief hatches can exceed regulatory standards, and several deaths have occurred after opening thief hatches. There is a paucity of information regarding the effects of COV inhalation in the lung. To address these knowledge gaps, the present hazard identification study was undertaken to investigate the effects of an acute, single inhalation exposure (6 h) or a 28 d sub-chronic exposure (6 h/d × 4 d/wk × 4 wks) to COV (300 ppm; Macondo well surrogate oil) on ventilatory and non-ventilatory functions of the lung in a rat model 1 and 28 d after acute exposure, and 1, 28 and 90 d following sub-chronic exposure. Basal airway resistance was increased 90 d post-sub-chronic exposure, but reactivity to methacholine (MCh) was unaffected. In the isolated, perfused trachea preparation the inhibitory effect of the airway epithelium on reactivity to MCh was increased at 90 d post-exposure. Efferent cholinergic nerve activity regulating airway smooth muscle was unaffected by COV exposure. Acute exposure did not affect basal airway epithelial ion transport, but 28 d after sub-chronic exposure alterations in active (Na+ and Cl¯) and passive ion transport occurred. COV treatment did not affect lung vascular permeability. The findings indicate that acute and sub-chronic COV inhalation does not appreciably affect ventilatory properties of the rat, but transient changes in airway epithelium occur.


Asunto(s)
Petróleo , Resistencia de las Vías Respiratorias , Animales , Exposición por Inhalación/efectos adversos , Pulmón , Cloruro de Metacolina/farmacología , Petróleo/toxicidad , Ratas
3.
Medicine (Baltimore) ; 100(41): e27344, 2021 Oct 15.
Artículo en Inglés | MEDLINE | ID: mdl-34731105

RESUMEN

BACKGROUNDS: Chronic obstructive pulmonary disease (COPD) is a common, preventable disease of airflow limitation that accounts for the third leading deaths of any disease process in the worldwide. Health benefits of liuzijue qigong (LQG) on patients with stable COPD has been assessed. This study was designed to perform a systemic review and meta-analysis of the effect of Liuzijue breathing exercise on patients with stable COPD. METHODS: Published articles from 1970 to December 2020 were conducted using electronic searches. Two independents reviewers conducted data extraction. The Cochrane risk of bias assessment tool was used to evaluate the quality of the included studies. RESULTS: A total of 16 eligible trials with 1039 patients with stable COPD were identified. Compared with control group, the pool meta-analysis of LQG showed a significant improvement in forced expiratory volume in one second (FEV1) (MD = -0.16, 95% CI [0.09, 0.23], P < .00001), FEV1% (MD = 9.71, 95% CI [8.44, 10.98], P < .00001), the ratio of forced expiratory volume to forced vital capacity in the first second (FEV1/FVC [%]) (MD = 4.81, 95% CI [2.12, 7.51], P = .0005), 6 minutes walking distance (6MWD) (MD = 21.89, 95% CI [14.67, 29.11], P < .00001), health-related quality of life (SMD = -0.84, 95% CI [-1.12,-0.55], P < .00001) and modified medical research council dyspnea scale (mMRC) (MD = -0.73, 95% CI [-0.96, -0.50], P < .00001). The observed effect was more pronounced for short term and medium-term duration interventions of study. It also showed improvements in the secondary outcome measures by LQG. CONCLUSIONS: In this systematic review and meta-analysis, LQG can improve lung ventilation function, exercise endurance and health-related quality of life of patients with stable COPD. ETHIC AND DISSEMINATION: This study is a systematic review and it does not involve harming to the rights of participants. Ethical approval will not be require for this study. The research results may be published in a peer-reviewed journals.


Asunto(s)
Enfermedad Pulmonar Obstructiva Crónica/terapia , Qigong , Resistencia de las Vías Respiratorias , Volumen Espiratorio Forzado , Resistencia Física , Calidad de Vida , Ensayos Clínicos Controlados Aleatorios como Asunto
4.
Comput Methods Programs Biomed ; 208: 106257, 2021 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-34245951

RESUMEN

OBJECTIVE: To evaluate the quantitative changes of respiratory functions for critically ill COVID-19 patients with mechanical ventilation, computational fluid dynamics (CFD) analysis was performed based on patient-specific three-dimensional airway geometry. METHODS: 37 cases of critically ill patients with COVID-19 admitted to the ICU of Huangshi Traditional Chinese Medicine Hospital from February 1st to March 20th, 2020 were retrospectively analyzed. 5 patients whose clinical data met the specific criteria were finally cataloged into death group (2 patients) and survival group (3 patients). The patient-specific three-dimensional airways were reconstructed from the central airways down to the 4th-5th bifurcation of the tracheobronchial tree. The volume changes of bronchi were calculated during the disease progression according to the comparison of two CT scans. Additionally, the changes of air flow resistance were analyzed using numerical simulation of CFD. RESULTS: Pearson correlation analysis demonstrated that there was negative correlation between the change of volume (ΔV) and the change of resistance (ΔR) for all COVID-19 patients (r=-0.7025). For total airway volume, an average decrease of -11.41±15.71% was observed in death group compared to an average increase of 1.86±10.80% in survival group (p=0.0232). For air flow through airways in lower lobe, the resistance increases for death group by 10.97±77.66% and decreases for survival group by -45.49±42.04% (p=0.0246). CONCLUSION: The variation of flow resistance in the airway could be used as a non-invasive functional evaluation for the prognosis and outcome of critically ill patients with COVID-19. The 'virtual' pulmonary function test by integrating follow-up CT scans with patient-derived CFD analysis could be a potentially powerful way in improving the efficiency of treatment for critically ill patients with COVID-19.


Asunto(s)
Resistencia de las Vías Respiratorias , COVID-19 , Enfermedad Crítica , Humanos , Hidrodinámica , Pulmón , Pronóstico , Estudios Retrospectivos , SARS-CoV-2
5.
Undersea Hyperb Med ; 48(2): 157-168, 2021.
Artículo en Inglés | MEDLINE | ID: mdl-33975406

RESUMEN

Introduction: Safe administration of critical care hyperbaric medicine requires specialized equipment and advanced training. Equipment must be tested in order to evaluate function in the hyperbaric environment. High-frequency percussive ventilation (HFPV) has been used in intensive care settings effectively, but it has never been tested in a hyperbaric chamber. Methods: Following a modified U.S. Navy testing protocol used to evaluate hyperbaric ventilators, we evaluated an HFPV transport ventilator in a multiplace hyperbaric chamber at 1.0, 1.9, and 2.8 atmospheres absolute (ATA). We used a test lung with analytical software for data collection. The ventilator uses simultaneous cyclic pressure-controlled ventilation at a pulsatile flow rate (PFR)/oscillatory continuous positive airway pressure (oCPAP) ratio of 30/10 with a high-frequency oscillation percussive rate of 500 beats per minute. Inspiratory and expiratory times were maintained at two seconds throughout each breathing cycle. Results: During manned studies, the PFR/oCPAP ratios were 26/6, 22/7, and 22.5/8 at an airway resistance of 20cm H2O/L/second and 18/9, 15.2/8.5, and 13.6/7 at an airway resistance of 50 cm/H2O/L/second at 1, 1.9, and 2.8 ATA. The resulting release volumes were 800, 547, and 513 mL at airway resistance of 20 cm H2O/L/sec and 400, 253, and 180 mL at airway resistance of 50 cm/H2O/L/sec at 1, 1.9, and 2.8 ATA. Unmanned testing showed similar changes. The mean airway pressure (MAP) remained stable throughout all test conditions; theoretically, supporting adequate lung recruitment and gas exchange. A case where HFPV was used to treat a patient for CO poisoning was presented to illustrate that HFPV worked well under HBO2 conditions and no complications occurred during HBO2 treatment. Conclusion: The HFPV transport ventilator performed adequately under hyperbaric conditions and should be considered a viable option for hyperbaric critical care. This ventilator has atypical terminology and produces unique pulmonary physiology, thus requiring specialized training prior to use.


Asunto(s)
Ventilación de Alta Frecuencia/instrumentación , Oxigenoterapia Hiperbárica/instrumentación , Lesión por Inhalación de Humo/terapia , Ventiladores Mecánicos , Acidosis/etiología , Anciano , Resistencia de las Vías Respiratorias , Presión Atmosférica , Intoxicación por Monóxido de Carbono/complicaciones , Femenino , Ventilación de Alta Frecuencia/métodos , Humanos , Oxigenoterapia Hiperbárica/métodos , Pulmón/fisiología , Respiración con Presión Positiva/instrumentación , Respiración con Presión Positiva/métodos , Intercambio Gaseoso Pulmonar/fisiología , Flujo Pulsátil , Valores de Referencia , Respiración
6.
Am J Otolaryngol ; 42(5): 103011, 2021.
Artículo en Inglés | MEDLINE | ID: mdl-33831820

RESUMEN

PURPOSE: Upper airway resistance syndrome (UARS) is a sleep related breathing disorder that was first described in 1993. This goal of this study is to determine the efficacy of surgical intervention for UARS. MATERIALS AND METHODS: Systematic review of the literature and a case series of UARS patients at a large integrated healthcare system. Meta-analysis was performed. RESULTS: For the systematic review, 971 abstracts were reviewed and 3 articles were included, yielding 49 subjects. All of the included studies were of level 3 or 4 evidence. Significant improvement in Epworth Sleepiness Scale (ESS) score was noted after surgery in two level 4 studies. No significant change in ESS was noted in one level 3 study. Our retrospective chart review of eleven UARS patients compared preoperative and postoperative ESS scores, as well as sleep study data. Patients underwent a variety of surgical procedures. Our findings show a significant improvement in mean ESS scores after surgery, from 11.0 (±3.5) to 7.0 (±4.8) with p = 0.01, though no difference in apnea hypopnea index (AHI) and respiratory disturbance index (RDI) were identified. Meta-analysis was performed on 2 studies from the systematic review and our cases series data. UARS surgery showed a mean change in ESS of -5.89 (95% CI, -8.29 to -3.50). CONCLUSIONS: This systematic review, meta-analysis and retrospective case series indicate that surgery may improve ESS scores in patients with UARS. AHI and RDI are unlikely to be impacted by surgery.


Asunto(s)
Resistencia de las Vías Respiratorias , Síndromes de la Apnea del Sueño/fisiopatología , Síndromes de la Apnea del Sueño/cirugía , Adulto , Femenino , Humanos , Masculino , Persona de Mediana Edad , Procedimientos Quirúrgicos Otorrinolaringológicos/métodos , Estudios Retrospectivos , Resultado del Tratamiento
7.
Ann Palliat Med ; 9(5): 3100-3106, 2020 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-32787373

RESUMEN

BACKGROUND: Coronavirus disease 2019 (COVID-19) caused by a new Betacoronavirus severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is currently a global pandemic. Gathered clinicopathological evidence in COVID-19 patients shows that alveoli injuries and interstitial changes are the major mechanisms of impaired O2/CO2 exchange. Few rehabilitation exercises concerning COVID-19 patients were reported. Here, we present a modified version of rehabilitation exercises based on the underlying mechanism of the disease to mild cases of COVID-19. These exercises aimed to improve the pulmonary function of patients and ease the expectoration process. Additionally, an essential branch of Traditional Chinese Medicine (TCM) named acupressure was integrated into the exercises to facilitate the recovery and maintenance of pulmonary function. METHODS: From March 4, 2020 to May 5, 2020, a total of 60 COVID-19 patients who completed the full course of MRE were enrolled in this observational study. The diagnostic and classification criteria were based on the 7th edition of Diagnosis and Treatment Guideline of COVID-19 published by the National Health Commission of the People's Republic of China. We prospectively gathered patients' reported outcomes concerning respiration-related symptoms at four different time points, including: (I) at admission; (II) at the time of hospital discharge; (III) two weeks after discharge; (IV) four weeks after discharge. The reported respiratory symptoms included dry cough, productive cough, difficulty in expectoration, and dyspnea. RESULTS: In total, 60 confirmed mild COVID-19 cases were enrolled with a median age of 54 years old. The baseline prevalence for dry cough, productive cough, difficulty in expectoration, and dyspnea were 41.7%, 43.3%, 35.0%, and 50.0%, respectively. The pronounced decline in symptom prevalence was recorded over time. Interestingly, four weeks after discharge, we noticed a lower remission rate in productive cough and difficulty in expectoration. CONCLUSIONS: The modified rehabilitation exercises were retrieved from the Eight-Section Brocade, and are specifically designed for rehabilitation of COVID-19 patients at home or health facilities. Based on current findings on pronouncedly improved remission rate in respiratory symptoms, we recommend the MRE as suitable rehabilitation exercise to smooth respiration and ease the expectoration process in mild COVID-19 cases.


Asunto(s)
Acupresión/métodos , Ejercicios Respiratorios/métodos , Infecciones por Coronavirus/rehabilitación , Ejercicios de Estiramiento Muscular/métodos , Neumonía Viral/rehabilitación , Adulto , Resistencia de las Vías Respiratorias , Betacoronavirus , COVID-19 , Infecciones por Coronavirus/fisiopatología , Tos/fisiopatología , Disnea/fisiopatología , Terapia por Ejercicio/métodos , Femenino , Humanos , Masculino , Persona de Mediana Edad , Pandemias , Neumonía Viral/fisiopatología , Intercambio Gaseoso Pulmonar , SARS-CoV-2 , Índice de Severidad de la Enfermedad , Resultado del Tratamiento
8.
J Microbiol Immunol Infect ; 53(6): 996-1007, 2020 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-32778497

RESUMEN

BACKGROUND: Asthma is a consequence of complex gene-environment interactions. Exploring the heterogeneity of asthma in different stages is contributing to our understanding of its pathogenesis and the development of new therapeutic strategies, especially in severe cases. OBJECTIVE: This study aimed to further understand the relationship between manifestations of acute and chronic asthma and various endotypes, and explore the severity of lung inflammation, cell types, cytokine/chemokine differences, and the effects of FIP-fve. MATERIALS AND METHODS: Acute and chronic OVA-sensitization mouse asthma models, based on our previously published method, were used and FIP-fve was used to evaluate the effect on these two models. BALF cytokines/chemokines were detected according to the manufacturer's protocol. RESULTS: Seventeen cytokine/chemokine secretions were higher in the chronic stage than in the acute stage. Whether in acute stage or chronic stage, the FIP-fve treatment groups had reduced airway hyperresponsiveness, infiltration of airway inflammatory cells, secretion of cytokines, chemokines by Th2 cells, and TNF-α, IL-8, IL-17, CXCL-1, CXCL-10, CCL-17, and CCL-22, and it was also found that the Treg cell cytokine IL-10 had increased significantly. PCA (Principal Component Analysis) was also used to compare statistics and laboratory data to find the important biomarkers in different stages and after treatment with FIP-fve. CONCLUSIONS: There are many different immune responses in the different stages of the asthma process. Drug treatment at the appropriate times might help reduce the worsening of asthma.


Asunto(s)
Asma/terapia , Citocinas/sangre , Desensibilización Inmunológica/métodos , Proteínas Fúngicas/uso terapéutico , Resistencia de las Vías Respiratorias/inmunología , Animales , Asma/inmunología , Asma/patología , Biomarcadores/sangre , Citocinas/inmunología , Modelos Animales de Enfermedad , Femenino , Proteínas Fúngicas/inmunología , Inmunoglobulina E/sangre , Inmunoglobulina G/sangre , Ratones , Ratones Endogámicos BALB C , Ovalbúmina , Análisis de Componente Principal
9.
N Engl J Med ; 382(6): 525-533, 2020 02 06.
Artículo en Inglés | MEDLINE | ID: mdl-32023372

RESUMEN

BACKGROUND: We previously reported the results of a trial of prenatal vitamin D supplementation to prevent asthma and recurrent wheeze in young children, which suggested that supplementation provided a protective effect at the age of 3 years. We followed the children through the age of 6 years to determine the course of asthma and recurrent wheeze. METHODS: In this follow-up study, investigators and participants remained unaware of the treatment assignments through the children's sixth birthday. We aimed to determine whether, when maternal levels of 25-hydroxyvitamin D were taken into account, children born to mothers who had received 4400 IU of vitamin D3 per day during pregnancy (vitamin D group) would have a lower incidence of asthma and recurrent wheeze at the age of 6 years than would those born to mothers who had received 400 IU of vitamin D3 per day (control group). Time-to-event methods were used to compare the treatment groups with respect to time to the onset of asthma or recurrent wheeze. Multivariate methods were used to compare longitudinal measures of lung function between the treatment groups. RESULTS: There was no effect of maternal vitamin D supplementation on asthma and recurrent wheeze in either an intention-to-treat analysis or an analysis with stratification according to the maternal 25-hydroxyvitamin D level during pregnancy. There was no effect of prenatal vitamin D supplementation on most of the prespecified secondary outcomes. We found no effects of prenatal supplementation on spirometric indexes. Although there was a very small effect on airway resistance as measured by impulse oscillometry, this finding was of uncertain significance. CONCLUSIONS: Vitamin D supplementation during the prenatal period alone did not influence the 6-year incidence of asthma and recurrent wheeze among children who were at risk for asthma. (Funded by the National Heart, Lung, and Blood Institute; VDAART ClinicalTrials.gov number, NCT00920621.).


Asunto(s)
Resistencia de las Vías Respiratorias/efectos de los fármacos , Asma/prevención & control , Suplementos Dietéticos , Atención Prenatal , Vitamina D/administración & dosificación , Vitaminas/administración & dosificación , Asma/epidemiología , Niño , Femenino , Estudios de Seguimiento , Humanos , Incidencia , Análisis de Intención de Tratar , Pulmón/efectos de los fármacos , Pulmón/embriología , Embarazo , Ruidos Respiratorios/efectos de los fármacos , Espirometría , Vitamina D/análogos & derivados , Vitamina D/sangre
10.
Pulm Pharmacol Ther ; 61: 101887, 2020 04.
Artículo en Inglés | MEDLINE | ID: mdl-31923458

RESUMEN

BACKGROUND: Cigarette smoke is the major cause of airway inflammatory disease, including airway hyperresponsiveness. Eucalyptol (EUC), also named 1.8-cineole, is a monoterpenoid found in essential oil of medicinal plants, showing several biological effects. HYPOTHESIS/PURPOSE: Based in the eucalyptol protective activity in respiratory diseases as asthma, our hypothesis is that eucalyptol is able to reduce the airway hyperresponsiveness and the respiratory mechanic parameters in rats exposed to cigarette smoke. STUDY DESIGN: Wistar rats were divided into control and cigarettes smoke (CS) groups. CS group was daily subjected to cigarette smoke and treated by inhalation for 15 min/day with EUC (1 mg/mL) or vehicle during 30 days. After treatment, bronchoalveolar lavage (BAL) was collected to analyze the inflammatory profile, and tracheal rings were isolated for evaluation of the airway smooth muscle hyperresponsiveness. Lung function was analyzed in vivo. METHODS: The inflammatory profile was evaluated by optical microscopy performing total (Neubauer chamber) and differential leukocyte count (smear slides stained in H&E). The hyperresponsiveness was evaluated in tracheal rings contracted with potassium chloride (KCl) carbamoylcholine (CCh), or Barium chloride (BaCl2) in presence or absence of nifedipine. The lung function (Newtonian resistance-RN) was evaluated by bronco stimulation with methacholine (MCh). RESULTS: BAL from CS group increased the influx of leukocyte, mainly neutrophils and macrophages compared to control group. EUC reduced by 71% this influx. The tracheal contractions induced by KCl, CCh or BaCl2 were reduced by EUC in 59%, 42% and 26%, respectively. The last one was not different of nifedipine activity. Newtonian resistance (RN) was also reduced in 37% by EUC compared to CS group. CONCLUSION: EUC reduces the hyperresponsiveness and the airway inflammatory profile, recovering the lung function.


Asunto(s)
Eucaliptol/farmacología , Mecánica Respiratoria/efectos de los fármacos , Fumar Tabaco/efectos adversos , Tráquea/efectos de los fármacos , Resistencia de las Vías Respiratorias/efectos de los fármacos , Animales , Recuento de Leucocitos , Leucocitos/efectos de los fármacos , Pulmón/efectos de los fármacos , Macrófagos/efectos de los fármacos , Masculino , Ratas , Ratas Wistar , Fumar
11.
Am J Physiol Lung Cell Mol Physiol ; 318(2): L296-L303, 2020 02 01.
Artículo en Inglés | MEDLINE | ID: mdl-31800263

RESUMEN

Asthma, a common disorder associated with airway inflammation and hyperresponsiveness, remains a significant clinical burden in need of novel therapeutic strategies. Patients are increasingly seeking complementary and alternative medicine approaches to control their symptoms, including the use of natural products. Ginger, a natural product that we previously demonstrated acutely relaxes airway smooth muscle (ASM), has long been reported to possess anti-inflammatory properties, although a precise mechanistic understanding is lacking. In these studies, we demonstrate that chronic administration of whole ginger extract or 6-shogaol, a bioactive component of ginger, mitigates in vivo house dust mite antigen-mediated lung inflammation in mice. We further show that this decrease in inflammation is associated with reduced in vivo airway responsiveness. Utilizing in vitro studies, we demonstrate that 6-shogaol augments cAMP concentrations in CD4 cells, consistent with phosphodiesterase inhibition, and limits the induction of nuclear factor-κB signaling and the production of proinflammatory cytokines in activated CD4 cells. Sustained elevations in cAMP concentration are well known to inhibit effector T cell function. Interestingly, regulatory T cells (Tregs) utilize cAMP as a mediator of their immunosuppressive effects, and we demonstrate here that 6-shogaol augments the Treg polarization of naïve CD4 cells in vitro. Taken together with previous reports, these studies suggest that ginger and 6-shogaol have the potential to combat asthma via two mechanisms: acute ASM relaxation and chronic inhibition of inflammation.


Asunto(s)
Asma/tratamiento farmacológico , Catecoles/uso terapéutico , Neumonía/tratamiento farmacológico , Zingiber officinale/química , Resistencia de las Vías Respiratorias/efectos de los fármacos , Animales , Antígenos CD/metabolismo , Antígenos Dermatofagoides/inmunología , Asma/complicaciones , Asma/inmunología , Asma/fisiopatología , Hiperreactividad Bronquial/complicaciones , Hiperreactividad Bronquial/inmunología , Hiperreactividad Bronquial/fisiopatología , Líquido del Lavado Bronquioalveolar/citología , Catecoles/administración & dosificación , Catecoles/farmacología , Recuento de Células , AMP Cíclico/metabolismo , Modelos Animales de Enfermedad , Femenino , Interleucina-4/metabolismo , Pulmón/patología , Masculino , Ratones Endogámicos C57BL , FN-kappa B/metabolismo , Extractos Vegetales/farmacología , Extractos Vegetales/uso terapéutico , Neumonía/complicaciones , Neumonía/inmunología , Neumonía/patología , Transducción de Señal/efectos de los fármacos , Linfocitos T Reguladores/efectos de los fármacos
12.
J Asthma ; 57(1): 11-20, 2020 01.
Artículo en Inglés | MEDLINE | ID: mdl-30634874

RESUMEN

Objective: New treatments are needed for cases of asthma that are refractory to traditional therapies. In this study, we examined the effect of oral nintedanib, an intracellular inhibitor of tyrosine kinases, on airway hyper-responsiveness (AHR) and airway smooth muscle cells, using a mouse model of experimental asthma. Methods: Asthma was experimentally induced in mice via subcutaneous injection of ovalbumin (OVA). A group of saline-injected mice served as a control group. The OVA mice were then divided into four treatment groups according to the dose of nintedanib. AHR was examined via exposure to vaporized methacholine. Airway inflammation was assessed via bronchoalveolar lavage fluid (BALF) cell counts and Th2 cytokine concentrations. Results: Baseline levels of AHR and airway inflammation were higher in OVA mice than in the control group. Treatment with nintedanib lowered AHR, BALF cell counts and BALF cytokine levels in a dose-dependent fashion. The effect of nintedanib was comparable to that of dexamethasone. In particular, treatment with nintedanib lowered the expression of transforming growth factor-ß1 and inhibited the expression and phosphorylation of platelet-derived growth factor receptor-ß, vascular endothelial growth factor receptor 1 (VEGFR1), VEGFR2, fibroblast growth factor receptor 2 (FGFR2), FGFR3, and extracellular signal-regulated kinase. Conclusions: Nintedanib lowered AHR and the expression of factors associated with airway inflammation and remodeling in a mouse model of experimental asthma. Our results suggest that nintedanib may be useful in the treatment of asthma.


Asunto(s)
Antiasmáticos/administración & dosificación , Asma/tratamiento farmacológico , Bronquios/efectos de los fármacos , Indoles/administración & dosificación , Mediadores de Inflamación/metabolismo , Enfermedad Aguda/terapia , Administración por Inhalación , Administración Oral , Remodelación de las Vías Aéreas (Respiratorias)/efectos de los fármacos , Remodelación de las Vías Aéreas (Respiratorias)/inmunología , Resistencia de las Vías Respiratorias/efectos de los fármacos , Resistencia de las Vías Respiratorias/inmunología , Animales , Asma/diagnóstico , Asma/inmunología , Bronquios/inmunología , Bronquios/metabolismo , Líquido del Lavado Bronquioalveolar/citología , Broncoconstrictores/administración & dosificación , Dexametasona/administración & dosificación , Modelos Animales de Enfermedad , Evaluación Preclínica de Medicamentos , Femenino , Glucocorticoides/administración & dosificación , Humanos , Mediadores de Inflamación/análisis , Cloruro de Metacolina/administración & dosificación , Ratones , Ovalbúmina/administración & dosificación , Ovalbúmina/inmunología
13.
Sleep Breath ; 23(4): 1359-1369, 2019 12.
Artículo en Inglés | MEDLINE | ID: mdl-31478126

RESUMEN

PURPOSE: To examine the craniofacial and airway morphology as well as the quality of life before and after passive myofunctional therapy (PMFT) for 1 year in children with obstructive sleep apnea (OSA). METHODS: Forty children with OSA wearing an oral device nightly (treatment group) and seventeen without the device (control group) were followed up for 1 year. Lateral cephalometric radiography, polysomnography (without participants wearing the oral device), and quality of life survey (OSA-18) were performed before and after the study period. RESULTS: The apnea-hypopnea index (AHI) during sleep, REM AHI, hypopnea count, and desaturation count in the treatment group dropped significantly, compared with the control group. The craniofacial linear measurements increased significantly in both groups, while the length of mandible (Co-Gn) and anterior facial height (N-Me) became significantly larger in the treatment group. For the airway morphology, the intergroup comparison showed that OPha-Ophp (distance between anterior and posterior sides of oropharynx) increased significantly in the treatment group. For quality of life, the intergroup comparison found statistically significant improvements in the following in the treatment group, based on the OSA-18 survey: loud snoring, dysphagia, mood swings, discipline problems, difficulty awakening, total score for the emotional distress portion, and total survey score. CONCLUSIONS: Preliminary evidence is substantiated for the benefits of 1-year PMFT using an oral device with a built-in tongue bead, including improvements in nasal breathing during sleep, mandible linear growth (Co-Gn and N-Me), airway morphology (OPha-Ophp), and patients' quality of life.


Asunto(s)
Resistencia de las Vías Respiratorias/fisiología , Cefalometría , Terapia Miofuncional , Calidad de Vida , Apnea Obstructiva del Sueño/terapia , Niño , Estudios de Cohortes , Estudios de Seguimiento , Humanos , Polisomnografía , Calidad de Vida/psicología , Apnea Obstructiva del Sueño/fisiopatología , Apnea Obstructiva del Sueño/psicología
14.
Am J Respir Cell Mol Biol ; 61(6): 702-712, 2019 12.
Artículo en Inglés | MEDLINE | ID: mdl-31144984

RESUMEN

Obesity is a risk factor for asthma, especially nonatopic asthma, and attenuates the efficacy of standard asthma therapeutics. Obesity also augments pulmonary responses to ozone, a nonatopic asthma trigger. The purpose of this study was to determine whether obesity-related alterations in gut microbiota contribute to these augmented responses to ozone. Ozone-induced increases in airway responsiveness, a canonical feature of asthma, were greater in obese db/db mice than in lean wild-type control mice. Depletion of gut microbiota with a cocktail of antibiotics attenuated obesity-related increases in the response to ozone, indicating a role for microbiota. Moreover, ozone-induced airway hyperresponsiveness was greater in germ-free mice that had been reconstituted with colonic contents of db/db than in wild-type mice. In addition, compared with dietary supplementation with the nonfermentable fiber cellulose, dietary supplementation with the fermentable fiber pectin attenuated obesity-related increases in the pulmonary response to ozone, likely by reducing ozone-induced release of IL-17A. Our data indicate a role for microbiota in obesity-related increases in the response to an asthma trigger and suggest that microbiome-based therapies such as prebiotics may provide an alternative therapeutic strategy for obese patients with asthma.


Asunto(s)
Microbioma Gastrointestinal/fisiología , Obesidad/complicaciones , Ozono/toxicidad , Hipersensibilidad Respiratoria/etiología , Resistencia de las Vías Respiratorias , Animales , Antibacterianos/farmacología , Antibacterianos/uso terapéutico , Asma/etiología , Asma/terapia , Celulosa/administración & dosificación , Fibras de la Dieta/administración & dosificación , Trasplante de Microbiota Fecal , Femenino , Fermentación , Microbioma Gastrointestinal/efectos de los fármacos , Vida Libre de Gérmenes , Ratones , Ratones Endogámicos C57BL , Ratones Obesos , Obesidad/genética , Obesidad/microbiología , Obesidad/fisiopatología , Pectinas/administración & dosificación , Pectinas/uso terapéutico , Receptores de Leptina/deficiencia , Hipersensibilidad Respiratoria/inducido químicamente , Hipersensibilidad Respiratoria/dietoterapia , Hipersensibilidad Respiratoria/microbiología
15.
Am J Speech Lang Pathol ; 28(1): 83-95, 2019 02 21.
Artículo en Inglés | MEDLINE | ID: mdl-30453332

RESUMEN

Purpose The aim of the study was to develop a treatment for athletes with paradoxical vocal fold motion disorder (PVFMD) based on exercise physiology and learning theory principles and administer it over a preestablished time frame. Method A prospective, repeated-measures, within-subject group design was used. Eleven adolescent/teen athletes diagnosed with PVFMD via laryngoscopy received short-term intensive (STI) therapy. Eight of the athletes returned for extended follow-up. Changes in postexercise inspiratory ( R i) and expiratory ( R e) resistances and Modified Borg Dyspnea Scale (MBDS) ratings collected at baseline were compared immediately posttreatment and at extended follow-up. Dyspnea Index scores were collected at baseline and at extended follow-up. Two no-treatment control athletes with PVFMD participated in two exercise challenges-baseline and 6 weeks later. Results Immediately after STI therapy, athletes attained significant improvement in R i, R e, and MBDS ratings. These changes were maintained at extended follow-up as well as a significant change in Dyspnea Index scores. The 2 control athletes who were reassessed 6 weeks after baseline experienced negative changes in postexercise R i and MBDS ratings. Conclusion STI therapy that incorporated individuality, specificity, and variable practice effectively changed outcome measures posttreatment with further improvement observed at extended follow-up. These results provide preliminary evidence for STI therapy for PVFMD.


Asunto(s)
Atletas , Ejercicios Respiratorios/métodos , Disfunción de los Pliegues Vocales/terapia , Adolescente , Resistencia de las Vías Respiratorias/fisiología , Niño , Disnea/diagnóstico , Disnea/etiología , Disnea/fisiopatología , Medicina Basada en la Evidencia/métodos , Ejercicio Físico/fisiología , Prueba de Esfuerzo/métodos , Femenino , Estudios de Seguimiento , Humanos , Laringoscopía , Masculino , Educación del Paciente como Asunto/métodos , Estudios Prospectivos , Índice de Severidad de la Enfermedad , Resultado del Tratamiento , Disfunción de los Pliegues Vocales/complicaciones , Disfunción de los Pliegues Vocales/fisiopatología
16.
Nan Fang Yi Ke Da Xue Xue Bao ; 38(11): 1372-1377, 2018 Nov 30.
Artículo en Chino | MEDLINE | ID: mdl-30514688

RESUMEN

OBJECTIVE: To investigate the effect of acupuncture on TGF-ß1/Smads signaling pathway in the lung tissue of mice with airway remodeling. METHODS: Thirty specific pathogen-free mice were randomly divided into blank group, model group and acupuncture group (n=10). Mouse models of asthma were established in the model group and the acupuncture group, and the mice in the latter group received 7 acupuncture therapies (at bilateral Fei Shu, Da Zhui and Zu Sanli, 20 min each time) every other day, starting on the 10th day after the modeling. At 24 h after the last acupuncture, the mice were subjected to inhalation of 1% OVA for 3 days, and 24 h after the last challenge, the mice were given methacholine chloride (Mch) inhalation at different concentrations for measurement of lung resistance using a noninvasive stroke volume meter. HE staining was used to observe the pathological changes in the lung tissues, and TGF-ß1 levels in the the bronchoalveolar lavage fluid (BALF) and serum were detected using ELISA; Western blotting was used to detect the differential protein expressions in the airway smooth muscles between the two groups. The airway smooth muscle cells were isolated from the mice in the acupuncture group and treated with a TGF- ß1 inhibitor (LY2157299), and the relative expressions of type-Ⅰ and Smads proteins were detected using Western blotting. RESULTS: The mice in the model showed obvious tracheal fistula with airway pathologies including lumen narrowing, bronchial mucosa thickening, dissociation of the epithelial cells, and thickening of the alveolar septum and airway smooth muscles. These pathological changes were obviously milder in the acupuncture group. The asthmatic mice exhibited significantly increased lung resistance in positive correlation with Mch concentration. Serum TGF-ß1 level was significantly elevated in asthmatic mice (P < 0.05); TGF-ß1 levels in the serum and BALF were significantly lower in the acupuncture group than in the model group (P < 0.05). In the model group, the expressions of α-SMA, TGF-ß1 and Smads in the airway smooth muscles were significantly higher than those in the other two groups (both P < 0.05). In cultured airway smooth muscle cells, the expressions of type-Ⅰ and Smads were significantly higher in cells treated with LY2157299 than in the control cells (P>0.05). CONCLUSIONS: Acupuncture can inhibit airway remodeling by inhibiting the expression of airway TGF-ß1 and down-regulating the expression of Smads and α-SMA to reduce airway inflammatory response. Airway expressions of type-Ⅰ and Smads proteins remain high after inhibiting TGF-ß1. Acupuncture may control asthma progression through the TGF-ß1/Smads pathway.


Asunto(s)
Terapia por Acupuntura , Remodelación de las Vías Aéreas (Respiratorias) , Asma/terapia , Pulmón/metabolismo , Proteínas Smad/metabolismo , Factor de Crecimiento Transformador beta1/metabolismo , Puntos de Acupuntura , Resistencia de las Vías Respiratorias , Animales , Asma/metabolismo , Asma/patología , Bronquios/patología , Progresión de la Enfermedad , Pulmón/fisiopatología , Ratones , Músculo Liso , Distribución Aleatoria , Proteínas Smad/análisis , Factor de Crecimiento Transformador beta1/análisis
17.
Medicine (Baltimore) ; 97(40): e12659, 2018 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-30290646

RESUMEN

BACKGROUND: Chronic obstructive pulmonary disease (COPD) is a leading cause of morbidity and mortality worldwide with a substantial and increasing social and economic burden. Liuzijue Qigong is a kind of traditional Chinese Qigong exercises that Traditional Chinese Medicine practitioners prescribe to individuals with COPD to strengthen the internal organs' function. Liuzijue Qigong was recommended for use in COPD rehabilitation, and some clinical trials indicate that Liuzijue Qigong would produce better functional capacity and quality of life of individuals with COPD. The objective of this study is to conduct a systematic review of the existing studies to assess effectiveness and safety of Liuzijue Qigong for the prevention or treatment of COPD in patients. METHODS: We will perform the comprehensive literature search in English and Chinese electronic database. The publication period will be from inception to the search date. In addition, the clinical trial registries, dissertations, informal publication, grey literature, reference lists of studies, systematic reviews, and conference abstracts will also be collected. Two reviewers will identify relevant studies, extract data information, and then assess the methodical quality by the Cochrane risk of bias assessment tool. Only randomized controlled trials comparing Liuzijue Qigong against other intervention or nonintervention will be included. Data will be synthesized by either fixed-effect or random-effect model regarding to a heterogeneity test. The routine lung function, arterial blood gas tensions, partial pressure of carbon dioxide, functional capacity, 30 seconds sit-to-stand test, respiratory function, maximal inspiration pressure, maximal expiratory pressure, airway resistance, and specific airway conductance will be assessed as primary outcomes. The secondary outcomes involved dyspnea, and fatigue levels, respiratory muscle strength, upper and lower limb muscle strength, handgrip strength test, and health-related quality of life and safety. Meta-analysis will be performed by using Cochrane's Review Manager software (version 5.3.5). RESULTS: This systematic review and meta-analysis will provide a high-quality synthesis and evaluate the efficacy and safety based on current relevant literature evidence of Liuzijue Qigong intervention for COPD patient. CONCLUSION: Our systematic review will provide evidence to determine whether Liuzijue Qigong is an effective and safe approach to prevention and treatment of COPD patients.


Asunto(s)
Fuerza Muscular/fisiología , Enfermedad Pulmonar Obstructiva Crónica/terapia , Qigong/métodos , Músculos Respiratorios/fisiopatología , Actividades Cotidianas , Resistencia de las Vías Respiratorias/fisiología , Análisis de los Gases de la Sangre , Disnea/complicaciones , Prueba de Esfuerzo , Fatiga/complicaciones , Fuerza de la Mano , Humanos , Enfermedad Pulmonar Obstructiva Crónica/complicaciones , Calidad de Vida , Proyectos de Investigación , Pruebas de Función Respiratoria , Revisiones Sistemáticas como Asunto
18.
Aerosp Med Hum Perform ; 89(11): 996-1001, 2018 Nov 01.
Artículo en Inglés | MEDLINE | ID: mdl-30352652

RESUMEN

INTRODUCTION: Performing at high altitude and scuba diving impose functional limitations to the respiratory system and impair exercise performance compared to normobaria. At altitude, the partial pressure of oxygen is reduced, which decreases arterial oxygen saturation and exercise performance. Falling arterial oxygen saturation results in hyperventilation and increased pulmonary ventilation. Diving poses unique effects on the respiratory system. The work of breathing is increased from marked increased airway resistance, static lung load, and hydrostatic pressure from the water on the thoracic wall. Both altitude and diving increase the work and energy cost of breathing, resulting in respiratory muscle fatigue. Respiratory muscle training (RMT) has been employed to target the deleterious effects on the respiratory system and exercise capacity. Although the literature is sparse, RMT has been reported to decrease the work and energy cost of breathing and improve pulmonary ventilation, respiratory muscle strength, pulmonary function, and exercise capacity. This narrative review summarizes what is currently known about RMT for exercise performance at altitude and in diving, including potential mechanisms and outlines gaps in the literature.Hess H, Hostler D. Respiratory muscle training effects on performance in hypo- and hyperbaria. Aerosp Med Hum Perform. 2018; 89(11):996-1001.


Asunto(s)
Altitud , Presión Atmosférica , Ejercicios Respiratorios/métodos , Buceo , Tolerancia al Ejercicio , Resistencia de las Vías Respiratorias , Humanos , Hiperventilación , Fatiga Muscular , Oxígeno , Presión Parcial , Ventilación Pulmonar , Respiración , Músculos Respiratorios
19.
Artículo en Inglés | MEDLINE | ID: mdl-29445271

RESUMEN

Background/hypothesis: Whole body exercise (WBE) changes lymphocyte subset percentages in peripheral blood. Resistive breathing, a hallmark of diseases of airway obstruction, is a form of exercise for the inspiratory muscles. Strenuous muscle contractions induce oxidative stress that may mediate immune alterations following exercise. We hypothesized that inspiratory resistive breathing (IRB) alters peripheral blood lymphocyte subsets and that oxidative stress mediates lymphocyte subpopulation alterations following both WBE and IRB. Patients and methods: Six healthy nonathletes performed two WBE and two IRB sessions for 45 minutes at 70% of VO2 maximum and 70% of maximum inspiratory pressure (Pimax), respectively, before and after the administration of antioxidants (vitamins E, A, and C for 75 days, allopurinol for 30 days, and N-acetylcysteine for 3 days). Blood was drawn at baseline, at the end of each session, and 2 hours into recovery. Lymphocyte subsets were determined by flow cytometry. Results: Before antioxidant supplementation at both WBE end and IRB end, the natural killer cell percentage increased, the T helper cell (CD3+ CD4+) percentage was reduced, and the CD4/CD8 ratio was depressed, a response which was abolished by antioxidants only after IRB. Furthermore, at IRB end, antioxidants promoted CD8+ CD38+ and blunted cytotoxic T-cell percentage increase. CD8+ CD45RA+ cell percentage changes were blunted after antioxidant supplementation in both WBE and IRB. Conclusion: We conclude that IRB produces (as WBE) changes in peripheral blood lymphocyte subsets and that oxidative stress is a major stimulus predominantly for IRB-induced lymphocyte subset alterations.


Asunto(s)
Resistencia de las Vías Respiratorias/efectos de los fármacos , Antioxidantes/administración & dosificación , Ejercicios Respiratorios/métodos , Linfocitos T CD4-Positivos/efectos de los fármacos , Linfocitos T CD8-positivos/efectos de los fármacos , Ejercicio Físico , Pulmón/efectos de los fármacos , Respiración/efectos de los fármacos , Adulto , Biomarcadores/sangre , Linfocitos T CD4-Positivos/inmunología , Linfocitos T CD4-Positivos/metabolismo , Antígeno CD56/sangre , Linfocitos T CD8-positivos/inmunología , Linfocitos T CD8-positivos/metabolismo , Citometría de Flujo , Antígenos HLA-DR/sangre , Humanos , Inmunofenotipificación/métodos , Antígenos Comunes de Leucocito/sangre , Pulmón/inmunología , Recuento de Linfocitos , Masculino , Malondialdehído/sangre , Fenotipo , Receptores de IgG/sangre
20.
Artículo en Chino | WPRIM | ID: wpr-771465

RESUMEN

OBJECTIVE@#To investigate the effect of acupuncture on TGF-β1/Smads signaling pathway in the lung tissue of mice with airway remodeling.@*METHODS@#Thirty specific pathogen-free mice were randomly divided into blank group, model group and acupuncture group (=10). Mouse models of asthma were established in the model group and the acupuncture group, and the mice in the latter group received 7 acupuncture therapies (at bilateral Fei Shu, Da Zhui and Zu Sanli, 20 min each time) every other day, starting on the 10th day after the modeling. At 24 h after the last acupuncture, the mice were subjected to inhalation of 1% OVA for 3 days, and 24 h after the last challenge, the mice were given methacholine chloride (Mch) inhalation at different concentrations for measurement of lung resistance using a noninvasive stroke volume meter. HE staining was used to observe the pathological changes in the lung tissues, and TGF-β1 levels in the the bronchoalveolar lavage fluid (BALF) and serum were detected using ELISA; Western blotting was used to detect the differential protein expressions in the airway smooth muscles between the two groups. The airway smooth muscle cells were isolated from the mice in the acupuncture group and treated with a TGF- β1 inhibitor (LY2157299), and the relative expressions of type-Ⅰ and Smads proteins were detected using Western blotting.@*RESULTS@#The mice in the model showed obvious tracheal fistula with airway pathologies including lumen narrowing, bronchial mucosa thickening, dissociation of the epithelial cells, and thickening of the alveolar septum and airway smooth muscles. These pathological changes were obviously milder in the acupuncture group. The asthmatic mice exhibited significantly increased lung resistance in positive correlation with Mch concentration. Serum TGF-β1 level was significantly elevated in asthmatic mice ( < 0.05); TGF-β1 levels in the serum and BALF were significantly lower in the acupuncture group than in the model group ( < 0.05). In the model group, the expressions of -SMA, TGF-β1 and Smads in the airway smooth muscles were significantly higher than those in the other two groups (both < 0.05). In cultured airway smooth muscle cells, the expressions of type-Ⅰ and Smads were significantly higher in cells treated with LY2157299 than in the control cells (>0.05).@*CONCLUSIONS@#Acupuncture can inhibit airway remodeling by inhibiting the expression of airway TGF-β1 and down-regulating the expression of Smads and -SMA to reduce airway inflammatory response. Airway expressions of type-Ⅰ and Smads proteins remain high after inhibiting TGF-β1. Acupuncture may control asthma progression through the TGF-β1/Smads pathway.


Asunto(s)
Animales , Ratones , Puntos de Acupuntura , Terapia por Acupuntura , Remodelación de las Vías Aéreas (Respiratorias) , Resistencia de las Vías Respiratorias , Asma , Metabolismo , Patología , Terapéutica , Bronquios , Patología , Progresión de la Enfermedad , Pulmón , Metabolismo , Músculo Liso , Distribución Aleatoria , Proteínas Smad , Metabolismo , Factor de Crecimiento Transformador beta1 , Metabolismo
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA